pf-04191834
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00723021)
Timeline
Indications
Mechanism of action
- Arachidonate 5-lipoxygenaseINHIBITOR
ALOX5 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-04191834
- pf-04191834
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01265732 | Phase 1 | Dec 1, 2010 | Pfizer |
| NCT01147458 | Phase 2 | Jul 1, 2010 | Pfizer |
| NCT00723021 | Phase 2 | Jul 1, 2008 | Pfizer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 3 | 2 | 2008 |
1 organizations
Page 1 / 1